Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis
Conclusion:
This systematic review will provide evidence for prophylactic antiplatelet/anticoagulant of severe COVID-19 patients.
PROSPERO registration:
CRD42020186928.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Clinical Trials | Coronavirus | COVID-19 | Databases & Libraries | Internal Medicine | International Medicine & Public Health | Pandemics | Pulmonary Thromboembolism | Respiratory Medicine | SARS | Science | Statistics | Study | Thrombosis | WHO